|
HS Code |
712908 |
| Chemical Name | 5,5-Diphenylhydantoin |
| Synonyms | Phenytoin |
| Molecular Formula | C15H12N2O2 |
| Molecular Weight | 252.27 g/mol |
| Cas Number | 57-41-0 |
| Appearance | White crystalline powder |
| Melting Point | 295-298°C |
| Solubility In Water | Practically insoluble |
| Logp | 2.47 |
| Pka | 8.3 |
| Storage Temperature | Room temperature |
| Usage | Anticonvulsant (antiepileptic drug) |
As an accredited 5,5-Diphenylhydantoin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque HDPE bottle labeled "5,5-Diphenylhydantoin, 25g." Tamper-evident seal, hazard symbols, batch number, and storage instructions included. |
| Shipping | 5,5-Diphenylhydantoin should be shipped in tightly sealed containers, protected from moisture and light. Transport in accordance with local, national, and international regulations for pharmaceuticals or chemicals. Ensure proper labeling and documentation. Store and ship at controlled room temperature, avoiding extreme heat, and handle carefully to prevent leaks or breakage during transit. |
| Storage | 5,5-Diphenylhydantoin should be stored in a tightly sealed container, protected from light and moisture. Keep the chemical in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizing agents. Ensure the storage area is clearly labeled and access is restricted to trained personnel to prevent unauthorized handling or accidental exposure. |
Applications of 5,5-Diphenylhydantoin in Industrial Manufacturing5,5-Diphenylhydantoin, also known as phenytoin, plays a crucial role in several specialized downstream industrial sectors. As a GMP-grade manufacturer, we supply this material to formulators, ingredient manufacturers, and processing plants incorporating it into regulated and value-added applications. Each key industrial scenario below details how phenytoin is applied, relevant compliance requirements, mixture ratios, process stage integration, and resulting finished products. 1. Active Pharmaceutical Ingredient for Anticonvulsant TabletsMultinational pharmaceutical companies utilize phenytoin as the main active ingredient in oral and parenteral dosage forms for seizure control. Raw material purity, traceable origin, and pharmaceutical GMP processing are essential, as this API directly enters human medicine. During granulation and tableting, formulators measure phenytoin concentration precisely to comply with strict dosage limits specified by regulatory agencies. Finished pharmaceutical tablets and injectable ampoules emerge after blending with approved fillers and excipients. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Chemical Intermediate in Advanced Organic SynthesisSpecialty chemical producers use 5,5-diphenylhydantoin as an intermediate in multi-step syntheses to obtain substituted hydantoins or for transformation to 5,5-diphenylimidazolidin-2,4-diones. The reactivity of the hydantoin ring provides various derivatization options in non-pharmaceutical fine chemical development. This sector demands high-purity input material matched to customized synthetic protocols, with batch records maintained for traceability in demanding QC environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Reference Standard for Analytical LaboratoriesAnalytical reagent manufacturers and pharmaceutical QC labs deploy 5,5-diphenylhydantoin as an HPLC/GC reference standard in impurity profiling and calibration protocols. Consistent assay value and certified traceability are critical for reproducible analytical results. Reference grade material supports method development, instrument calibration, and routine batch sample testing, particularly within regulated drug supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Component for Veterinary FormulationsVeterinary pharmaceutical manufactures formulate 5,5-diphenylhydantoin for canine and equine anticonvulsant treatments. Product safety and efficacy demand raw material certification and adherence to veterinary regulatory authority specifications (such as VMD or FDA-CVM). Formulators incorporate the ingredient within oral or injectable preparations according to species-specific dosing guidelines, with tailored excipient systems for animal use. End products are batch-tested for uniform content and stability prior to commercial release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 5,5-Diphenylhydantoin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the chemical manufacturing world, consistency and reliability mean everything. Over years of working directly with the synthesis and refinement of 5,5-Diphenylhydantoin, we’ve learned that each lot reflects not just chemistry, but long-standing experience and careful process control. Our team starts with high-purity raw materials that we source via verified suppliers and validated production chains, because one flaw early on can unwind any effort downstream. Unlike third-party sellers, every drum of 5,5-Diphenylhydantoin comes from reaction vessels and purification steps managed in-house by our trained staff, ensuring traceability from start to finish.
Sometimes known as phenytoin, this compound holds a long-standing reputation in both pharmaceutical and chemical circles. As a manufacturer, we recognize its core advantage stems from a unique combination of structural rigidity, hydantoin backbone, and dual phenyl groups. These characteristics drive its primary use in anticonvulsant medication formulations, where stability, purity, and predictable behavior under a range of processing conditions really matter.
A common request we receive centers around specific model and specification choices, so we invest in regularly updating our quality control protocols. Most customers require active pharmaceutical ingredient (API) grade 5,5-Diphenylhydantoin, typically characterized by purity well above 99%. Each batch undergoes layered testing: from HPLC for organic impurities, through wet chemical and spectrometric analysis, to microbial and heavy metal assessment. Rather than rely on a one-size-fits-all approach, we tailor our process to batch size requirements, whether for kilogram-scale research applications or multi-ton orders for generics production.
To provide some perspective, we maintain strict controls over melting point and moisture content. Every worker in our facility understands lower-grade materials can undermine downstream tableting or blending. We’ve responded to customer audits by adding more rigorous sieve analysis, monitoring particle size distribution, and tracking polymorphic forms. Over the years, we’ve noticed even minor variations in crystalline habit can lead to processing headaches or regulatory questions.
Our standard release specifications for 5,5-Diphenylhydantoin usually feature:
Decades supplying this molecule to the pharmaceutical sector have sharpened our grasp of what counts. In a typical process, phenytoin serves as the core API for oral tablets or capsules, predominantly for management of epilepsy and other seizure disorders. The API’s sensitivity to thermal and oxidative stress means manufacturers need dependable shelf-life data, with genuine evidence of stability under varied storage conditions.
Batch-to-batch reproducibility backs therapeutic consistency across patient populations. Dose uniformity calls for precisely milled, free-flowing powder, without agglomeration or visible contaminants. Problems usually show up not during synthesis, but at scale-up or when blending with excipients. We work closely with our customers, often discussing their process flowcharts, to anticipate challenges before a major campaign is underway.
Through years of dialogue with large and small formulators, we’ve picked up that seemingly minor details, like electrostatic potential or residual solvents, can trigger costly stoppages. Regular feedback loops drive our efforts in refining drying protocols, containment, and de-dusting during milling. Over time, we have eliminated sources of batch contamination that might escape notice at smaller scale.
Competitors often cite purity and price, but the reality on the ground shows not all products reach the same functional standard. We’ve received samples from various market sources, some revealing unexpected contaminants, polymorphic instability, or inadequate documentation. In contrast, our approach has always started with the end user in mind.
Customers sometimes share stories about delayed approvals or recalls, often linked to insufficient quality oversight. We hear concerns about off-brand phenytoin failing dissolution, batch failing identification, or particles forming unusual aggregates during process steps. Through robust in-process controls, real-time analytics, and meticulous cleaning validation, we cut risk from every production tier. This dedication moves beyond compliance into a culture where each staff member owns both failures and successes. Completion of every batch release comes only after reaching agreement between production, quality assurance, and laboratory teams.
Complex market dynamics drive choices about sourcing, but our customers recognize that short-term savings with unverified material rarely justifies the long-term disruption from a failed lot. When a company’s own products depend on unwavering supply of critical inputs, partnering with an experienced manufacturer means more than supply— it means risk reduction, predictable quality, and a buffer against regulatory snags.
While best known as a pharmaceutical active, 5,5-Diphenylhydantoin also features in several research contexts. Laboratories focusing on organic synthesis sometimes draw on its hydantoin scaffold for structure–activity relationship studies or as an intermediate in more complex chemical pathways. In industrial polymer chemistry, its aromatic structure occasionally finds niche applications as a monomer precursor or specialty additive.
Our research partners have asked for customized grades, whether micronized fine powders, specific solvent residue profiles, or solvent-free variants. By operating our R&D and production centers under unified management, we respond to these requests without routing through third parties, reducing response time and ensuring consistency.
Adapting equipment for fine particle control or integrating new analytical tools means real investment in hardware and training. This direct contact with users—be they process engineers or QC chemists—gives us early warning if a new downstream test or formulation requirement emerges. We update our systems not as a marketing slogan, but as daily necessity, because variance or skill gaps translate directly into product risk.
Our decades in the field remind us that paperwork carries as much weight as chemistry. A strong 5,5-Diphenylhydantoin supplier delivers not only a physical product, but complete Drug Master Files, full traceability, validated methods, and transparent deviation logs. Health authorities and audit teams pay close attention to origin, cross-contamination, and process reproducibility. Every major regulatory change—new impurity limits, revised test methods, updated stability requirements—triggers a meticulous review session in both laboratory and shop floor.
We work directly with regulatory agencies to keep our dossiers current. Customers benefit from pre-audit documentation reviews, and our staff routinely supports clients during their site inspections. Growing scrutiny around nitrosamines, elemental impurities, and extractable entities has raised industry standards, especially for drugs in chronic use.
Long-term experience in chemical manufacturing means tracking not just our own production, but every node in the supply chain. Political shifts, environmental regulation, and raw material shortages affect supply reliability. Our site managers forecast demand and build reserve stocks when necessary, using local warehousing and distributed manufacturing infrastructure to backstop main production lines. We invest in security of supply contracts and respond early to tight markets, communicating directly with anchor customers rather than relying on brokers.
Many of our clients have faced shortages during bulk ingredient disruptions. We take pride in being able to redirect material or quickly switch production schedules, ensuring consistent delivery even under challenging conditions. The trust we build results from showing up and solving problems, not just offering a list of products. Our experience in cross-border logistics and international compliance has shielded clients during outbreaks, transport strikes, and regulatory embargoes.
Talking shop with engineers and QC chemists—rather than sales intermediaries—leads to better solutions. Our production, documentation, and customer service departments operate in tight communication so that custom requirements, urgent requests, or technical questions never vanish into a generic customer support portal. Site visits, technical audits, and collaborative troubleshooting flatten communication barriers.
Clients often appreciate opportunities to visit our facilities or participate in remote audits. Walk-throughs with our operators, line supervisors, and process engineers uncover fine details about process steps, equipment cleaning, and quality sampling. This transparency improves confidence, reduces misunderstandings, and lowers the cost of technical change management.
Problems can and do occur, especially on large, multi-lot campaigns. What defines a strong manufacturer isn’t the promise of zero flaws, but active, ongoing effort to engage with those issues openly and effectively. As one production chemist put it after troubleshooting a polymorph issue, “It’s about closing the loop—not just fixing the batch, but fixing the system.” That sums up our work ethic.
Markets change, and so too must manufacturers. In our experience, demand signals move quickly: a reformulation in a developed market, a new regulatory restriction in an emerging economy, a novel synthetic pathway in academic literature—each triggers internal review and, often, process adjustment. Unlike a trading company, we adjust plant schedules, re-validate cleaning methods, or scale capacity to match real-world shifts rather than just pass forecasts up a supply chain.
Long-term product support sometimes means holding older processes open even as the bulk of volume moves to updated technology, simply because legacy applications depend on a specific polymorph, particle size or impurity profile. We work with formulation teams to optimize stability programs, provide documentation for patent fillings, or engineer improvements to packaging for improved shipping stability and reduced humidity uptake, particularly for container shipments in extreme climates.
We approach 5,5-Diphenylhydantoin not as a commodity but as a critical input where trace-level details can make or break a product’s therapeutic promise. Instead of chasing buzzwords or standards alone, our team works overtime to update analytical methods, stay ahead of impurity trends, and build feedback into daily production meetings. Our chemists regularly participate in industry consortia and scientific meetings to benchmark quality, gather insight, and share problem-solving strategies.
Manufacturing is more than steel tanks and white powder; it’s a deliberate culture of learning, testing, and support. We judge ourselves not by shipments alone, but by the long shelf life, consistent potency, and predictable processability apparent in every batch. Feedback from partners makes us sharper, and we build change into our DNA by training new operators, rotating responsibilities, and conducting documented audits.
Chemical manufacturing today means more scrutiny, faster timelines, and higher expectations from every stakeholder. Our business grows by showing up, asking questions, and diving into problems, not by rebranding or relabeling another supplier’s work. The best endorsement we earn isn’t on paper, but in shared troubleshooting sessions or swift response during a client’s time of need.
Over the years, we’ve come to see that partnerships last where reliability, open support, and technical engagement form the foundation. 5,5-Diphenylhydantoin presents unique manufacturing, quality, and regulatory challenges that reward careful attention, early engagement, and stubborn persistence. Our goal remains simple: supply this vital product consistently, safely, and at the technical level each customer’s process demands, every time. Every container we ship embodies a history of lessons learned, a promise kept, and a relationship strengthened over years of direct, transparent, technical effort.